Broadwood Partners, L.P. Staar Surgical CO (STAA) insider trading activity

Broadwood Partners, L.P. is > 10% Shareholder of STAAR SURGICAL CO. Currently has a direct ownership of 10.8 Million shares of STAA, which is worth approximately $308 Million. The most recent transaction as insider was on Dec 29, 2022, when has been sold 39,090 shares (Common Stock) at a price of $47.93 per share, resulting in proceeds of $1,873,583. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.8M

0% 3M change

12.01% 12M change

Total Value Held $308 Million

BROADWOOD PARTNERS, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 29 2022	BUY Open market or private purchase	$1,873,583 $47.93 p/Share	39,090 Added 0.44%	8,783,082 Common Stock
Dec 28 2022	BUY Open market or private purchase	$4,698,000 $46.98 p/Share	100,000 Added 1.13%	8,743,992 Common Stock
Dec 27 2022	BUY Open market or private purchase	$2,490,601 $47.91 p/Share	51,985 Added 0.6%	8,643,992 Common Stock
Oct 01 2021	SELL Other acquisition or disposition	-	71,577 Reduced 0.83%	8,592,007 Common Stock
Jul 01 2021	SELL Other acquisition or disposition	-	655 Reduced 0.01%	8,663,584 Common Stock
Jun 28 2021	SELL Open market or private sale	$20,174,700 $155.19 p/Share	130,000 Reduced 1.48%	8,664,239 Common Stock
Jun 25 2021	SELL Open market or private sale	$4,789,742 $155.84 p/Share	30,735 Reduced 0.35%	8,794,239 Common Stock
Jun 24 2021	SELL Open market or private sale	$10,686,354 $157.83 p/Share	67,708 Reduced 0.76%	8,824,974 Common Stock
Jun 18 2021	SELL Open market or private sale	$2,019,681 $152.59 p/Share	13,236 Reduced 0.15%	8,892,682 Common Stock
Jun 17 2021	SELL Open market or private sale	$9,604,208 $150.31 p/Share	63,896 Reduced 0.71%	8,905,918 Common Stock
Jun 16 2021	SELL Open market or private sale	$4,544,493 $148.79 p/Share	30,543 Reduced 0.34%	8,969,814 Common Stock
Jun 15 2021	SELL Open market or private sale	$5,217,135 $147.46 p/Share	35,380 Reduced 0.39%	9,000,357 Common Stock
Jun 14 2021	SELL Open market or private sale	$3,235,862 $147.79 p/Share	21,895 Reduced 0.24%	9,035,737 Common Stock
Jun 11 2021	SELL Open market or private sale	$334,539 $147.05 p/Share	2,275 Reduced 0.03%	9,057,632 Common Stock
Jun 01 2021	SELL Open market or private sale	$148,409 $146.36 p/Share	1,014 Reduced 0.01%	9,059,907 Common Stock
May 28 2021	SELL Open market or private sale	$32,094,477 $147.43 p/Share	217,693 Reduced 2.35%	9,060,921 Common Stock
May 27 2021	SELL Open market or private sale	$6,822,633 $143.42 p/Share	47,571 Reduced 0.51%	9,278,614 Common Stock
Apr 26 2021	SELL Open market or private sale	$5,869,720 $135.3 p/Share	43,383 Reduced 0.46%	9,326,185 Common Stock
Apr 23 2021	SELL Open market or private sale	$7,190,047 $133.51 p/Share	53,854 Reduced 0.57%	9,369,568 Common Stock
Apr 22 2021	SELL Open market or private sale	$2,693,997 $130.34 p/Share	20,669 Reduced 0.22%	9,423,422 Common Stock
Apr 01 2021	SELL Bona fide gift	-	100,000 Reduced 1.05%	9,444,091 Common Stock
Feb 12 2021	SELL Open market or private sale	$2,763,895 $124.22 p/Share	22,250 Reduced 0.23%	9,544,091 Common Stock
Feb 11 2021	SELL Open market or private sale	$922,868 $124.51 p/Share	7,412 Reduced 0.08%	9,566,341 Common Stock
Feb 10 2021	SELL Open market or private sale	$972,846 $124.9 p/Share	7,789 Reduced 0.08%	9,573,753 Common Stock
Feb 09 2021	SELL Open market or private sale	$8,075,901 $124.09 p/Share	65,081 Reduced 0.67%	9,581,542 Common Stock

Also insider at

LCTX

Lineage Cell Therapeutics, Inc. Healthcare

Director

CMRO

COMARCO INC

> 10% Shareholder

OCX

Oncocyte Corp Healthcare

> 10% Shareholder

BPL